Healthcare
Birdsong Health Literacy Center of Excellence Appoints Jacqueline Schillereff as Executive Director
Jul 13 · 20:35Newswire.com
3,170 press releases indexed under healthcare.
American Thoracic Society workshop report underscores rapid disease progression and identifies elimination of the hazard as the most effective means of protection NOVATO, Calif., July 13, 2026 /PRNewswire/ -- A newly released medical report from the American Thoracic Society is bringing...
Names Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise Transformation ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:...
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance
Elk Grove Foot and Ankle Clinic announces its grand opening on Aug. 1, 2026, at 9075 Elk Grove Blvd., Suite 220A, in Old Town Elk Grove. Founded by Dr. Christina Garvin, AACFAS, the practice brings specialized medical foot care and a patient-first model to the community. The clinic offers comprehensive conservative care, streamlined digital check-ins, and convenient same-day appointments. [PR.com]
CLEVELAND, July 13, 2026 /PRNewswire/ -- Cleveland Medical Devices Inc. announced that proceedings before the Patent Trial and Appeal Board have now produced favorable outcomes for Cleveland Medical Devices in five of the six inter partes review petitions filed by ResMed against patents...
SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell, subject to market and other conditions, $500.0 million of shares of its common stock in a proposed underwritten public offering. All of the shares of common stock to be sold in the proposed offering are being offered by Erasca. In addition, Erasca intends to grant the underwriters a 30-day option to purchase up to an additional $75.0 million of shares of its common stock. There can be no assurance as to whether or when the proposed public offering may be completed, or as to the actual size or terms
CARMEL, Ind. and BURLINGTON, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that its Board of Directors has appointed Steve Hoerter, current Executive Chairman of the Board, as its new Chairman and Chief Executive Officer. Mr. Hoerter succeeds Kent Hawryluk, who will step down as President, Chief Executive Officer and a member of the Board of Directors. In addition, the Board has appointed John Smither, current Interim Chief Financial Officer, as the Company’s new Chief Financial Officer. All leadership changes are effective immediately.
VANCOUVER, British Columbia, July 13, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“ Eupraxia ” or the “ Company ”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced updates to its executive leadership and operating structure as the Company continues to prepare for its next stage of clinical and commercial development.
IRVINE, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that Aziz Mottiwala, Chief Commercial Officer, is departing the Company to pursue a new opportunity as Chief Executive Officer of a public medical device company. Effective immediately, Neera Clase, formerly Senior Vice President of Market Access, will serve as Interim Chief Commercial Officer while Tarsus conducts a search for a permanent successor.
Peptide stacking has moved from bodybuilding forums and biohacker circles into everyday wellness searches. Patients are now hearing about combinations for weight loss, recovery, muscle support, skin, energy, longevity, inflammation, and metabolic health. The problem is not that patients are curious. The problem is that many people are learning about peptide stacks from TikTok clips, influencer protocols, private message sellers, and vials labeled "research use only." California Trim Clinic offers a different pathway. The clinic does not sell R&D peptides, gray-market peptides, or black-market vials. It provides doctor-prescribed, patient-specific compounded peptide care through licensed pharmacy partners when medically appropriate and legally permitted. Patients interested in learning
Un rapport met en avant l'énergie propre, l'innovation et la reconnaissance des critères ESG ZIBO, Chine, 13 juillet 2026 /PRNewswire/ -- INTCO Medical (« la Société »), l'un des principaux fabricants mondiaux de gants jetables, a publié son rapport 2025 sur les enjeux environnementaux,...